| Line Item | 2025-12-28 | Y/Y |
|---|---|---|
| Revenue | $31.8M | +37.9% |
| Cost of Revenue | $25.7M | +2.4% |
| Gross Profit | $6.1M | +398.5% |
| R&D Expense | $110.3M | -11.4% |
| SG&A Expense | $73.0M | -1.7% |
| Operating Income | -$177.3M | +27.0% |
| Interest Expense | $12.4M | +82.3% |
| Pre-tax Income | -$157.9M | +29.5% |
| Income Tax | -$1.3M |
| Line Item | 2025-12-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $106.0M | -61.1% |
| Short-term Investments | $406.0M | — |
| Accounts Receivable | $4.4M | -3.2% |
| Inventory | $13.6M | +77.7% |
| Current Assets | $542.2M | +83.8% |
| Total Assets | $879.0M | +66.7% |
| Current Liabilities | $65.0M | +21.1% |
| Line Item | 2025-12-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$95.3M | +12.3% |
| Capital Expenditures | $18.2M | -76.1% |
| Investing Cash Flow | -$538.3M | — |
| Financing Cash Flow | $467.4M | +210.0% |
| Free Cash Flow | -$113.5M | +38.6% |
| +5.7% |
| Net Income | -$156.7M | +29.5% |
| EPS (Basic) | -$0.75 | +40.9% |
| EPS (Diluted) | -$0.75 | +40.9% |
| Long-term Debt |
| $519.5M |
| +205.6% |
| Total Liabilities | $605.0M | +117.8% |
| Stockholders' Equity | $271.2M | +9.9% |